Risks, severity and timing of infections in patients with multiple myeloma: a longitudinal cohort study in the era of immunomodulatory drug therapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|7-1048|1|100-108

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.7-1048, Iss.1, 2015-10, pp. : 100-108

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risks, severity and timing of infections in patients with multiple myeloma: a longitudinal cohort study in the era of immunomodulatory drug therapy

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 171, Iss. 1, 2015-10 ,pp. : 100-108

John Wiley & Sons Inc

Access to resources Recommend Favorite

Retreatment and prolonged therapy with subcutaneous bortezomib in patients with relapsed multiple myeloma: A randomized, controlled, phase III study

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 100, Iss. 1, 2018-01 ,pp. : 10-19

John Wiley & Sons Inc

Access to resources Recommend Favorite

Recurrent cardiotoxicity potentiated by the interaction of proteasome inhibitor and immunomodulatory therapy for the treatment of multiple myeloma

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 180, Iss. 2, 2018-01 ,pp. : 271-275

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antiangiogenic Therapy in Multiple Myeloma

By  

Acta Haematologica, Vol. 106, Iss. 4, 2002-01 ,pp. : 208-213

Karger

Access to resources Recommend Favorite

Multiple‐Dose Oritavancin Evaluation in a Retrospective Cohort of Patients with Complicated Infections

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 38, Iss. 1, 2018-01 ,pp. : 152-159

John Wiley & Sons Inc

Access to resources Recommend Favorite